Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Analysis of the clinical impact of the diagnostic reclassification of brain gliomas according to the World Health Organization classification (2016)].

Revista de neurologia - 16 Nov 2019

Mateo-Sierra O, Alcalá-Torres J, Serret-De Troya C, Valera-Melé M, Solá-Vendrell E

Abstract excerpt

INTRODUCTION: Since the introduction of genetic and molecular criteria in the 2016 World Health Organization (WHO) classification of brain tumours, there has been a diagnostic reclassification between certain astrocytomas and oligodendro-gliomas with histological and genetic discordances, the prognosis of which is unknown. AIM: To analyse the implications of the diagnostic reclassification of brain gliomas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Neoplasm Grading

Share to Oligodendroglioma

Share to World Health Organization

Source

Identifiers

PMID: 31713226
DOI: 10.33588/rn.6910.2019256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Analysis of the clinical impact of the diagnostic reclassification of brain gliomas according to the World Health Organization classification (2016)].PMID 31713226Read ↗

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Semantic proximity Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016Semantic proximity Read ↗

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of RevisionSemantic proximity Read ↗

[Classification of gliomas. Current progress and perspectives].Semantic proximity Read ↗

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Semantic proximity Read ↗

Real-life implementation of molecular criteria for diagnosing gliomas according to 2021 WHO Classification: a national survey from the Italian Association of Neuro-Oncology and Society of Neurosurgery.Semantic proximity Read ↗

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.Semantic proximity Read ↗

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.Semantic proximity Read ↗

Analysis of Isocitrate dehydrogenase (IDH) mutation in Gliomas: A call for neurosurgeons and pathologists in Pakistan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.